N.D. Ill.: Neither Statutory Estoppel nor “Misleading” Statements Regarding Its Scope Sufficient to Knock Out Invalidity Defenses

Sep 30, 2020

Reading Time : 3 min

Earlier in the district court litigation, the patent owner had asserted four patents. The defendant then petitioned for inter partes review (IPR) at the Patent Trial and Appeal Board (PTAB). During the pendency of the institution decisions, the defendant served its final invalidity contentions in the district court, identifying anticipation and obviousness grounds that all included prior art products. The PTAB instituted the IPR petitions, and the defendant then sought and obtained a stay in district court pending the outcome of the IPR proceedings. The PTAB found unpatentable the claims of one of the four patents asserted in district court. Thereafter, the court lifted the stay, and the parties disputed the scope of the statutory IPR estoppel and whether the defendant was judicially estopped from bringing its prior art arguments. Patent owner argued that the court should look to whether the product was described and disclosed in a publication that could have been raised in an IPR.

The court began its analysis by noting the absence of appellate court precedent on the scope of statutory estoppel, as well as the current division of opinion among district courts. By considering how the term “ground” had been construed in other aspects of IPR proceedings, the court interpreted “ground” to mean “the specific piece of prior art or combination of prior art that a petitioner raised, or could have raised, to challenge the validity of a patent claim during an IPR.” As such, the court ruled estoppel does not apply to prior art products. The court acknowledged that a defendant could not avoid estoppel to a ground that relied on printed materials merely because the “materials reflect or represent a prior art product.” But the court concluded that such was not the case here because the defendant’s claim charts, “replete with photographs” of the products, showed that the defendant intended to argue that the actual products disclosed limitations of the claims.

The court then considered whether to apply judicial estoppel to the prior art grounds in light of the defendant’s representations made when seeking a stay. On this issue, the court considered its regional circuit’s three-part test. First, the court determined that the defendant’s current estoppel argument was “clearly inconsistent” with its earlier representations on case-narrowing following an IPR. The defendant had previously argued that it would have to narrow its invalidity positions in light of the outcome of the IPRs. When the defendant made those statements, it had already served its final invalidity contentions which included prior art invalidity grounds that all included prior art products. Thus, this factor favored application of judicial estoppel because the defendant’s pre-stay statement was inconsistent with its post-IPR argument that it was not required to narrow any of its prior art grounds.

For the next factor of the circuit law test, the court found that the defendant’s earlier position had succeeded in persuading the court to stay the case pending the outcome of the IPRs. The court’s stay ruling was based, in part, on potential simplification of the invalidity issues. As such, this factor also favored application of judicial estoppel.

Under the final factor of the circuit law test, however, the court found that it would not be unfair to the patent owner to allow the defendant to proceed with its prior art invalidity theories. The court found that the defendant’s assertions, although misleading, were “not so egregious or manipulative as to warrant wholesale preclusion of its prior art invalidity theories.” The court explained that it granted a stay based on several factors, including no disadvantage to the patent owner and the potential to remove claims from the case. The court further explained that the patent owner had been able to prepare responses to the invalidity grounds for over a year and could rely on relevant work from the IPR proceedings.

Considering the three factors and using its “equitable judgment and discretion,” the court decided that the patent owner was “not entitled to a knockout blow on [the defendant’s] prior art invalidity arguments.”

Practice Tip: The jurisprudence of estoppel continues to develop through district court decisions. Regarding statutory estoppel, in the absence of binding precedent, a defendant may be well-served by making explicit reference to the features of a prior art product as opposed to a printed publication describing the product. A patent owner should, on the other hand, scrutinize the defendant’s invalidity grounds and, where the parties have made arguments to the court about a stay, the patent owner should consider the defendant’s pre-stay and post-IPR representations concerning the simplification of the case. Concomitantly, in light of the potential for a party to be judicially estopped, litigants should pay close attention to the arguments raised for or against a stay pending an IPR outcome.

Medline Indus., Inc. v. C.R. Bard, Inc., No. 17 C 7216, 2020 WL 5512132 (N.D. Ill. Sept. 14, 2020)

Share This Insight

Previous Entries

IP Newsflash

March 24, 2025

The Federal Circuit affirmed a Patent Trial and Appeal Board (PTAB) final written decision holding that the prior art exception of AIA Section 102(b)(2)(B) does not apply to a prior sale by an inventor when the sale is conducted in private. According to the Federal Circuit, a sale must disclose the relevant aspects of the invention to the public to qualify for the prior art exception of Section 102(b)(2)(B).

...

Read More

IP Newsflash

March 21, 2025

Under the Lanham Act, a plaintiff who prevails on a trademark infringement claim may be entitled to recover the “defendant’s profits” as damages. The Supreme Court in Dewberry Group, Inc. v. Dewberry Engineers Inc. unanimously construed “defendant’s profits” in 35 USC § 1117(a) to mean that only the named defendant’s profits can be awarded, not the profits of other related corporate entities. The Court, however, left open the possibility that other language in § 1117(a) may allow for damages linked to the profits of related entities, if properly raised and supported.

...

Read More

IP Newsflash

March 13, 2025

In a series of rulings on a motion in limine, the District of Delaware recently distinguished between what qualifies as being incorporated by reference and what does not for the purposes of an anticipation defense. In short, a parenthetical citation was held to be insufficient, while three passages discussing a cited reference met the test.

...

Read More

IP Newsflash

March 4, 2025

On February 28, 2025, the USPTO announced that it was rescinding former Director Vidal’s 2022 memorandum on discretionary denials by the Patent Trial and Appeal Board. The 2022 memorandum effectively narrowed the application of discretionary denials in cases with parallel district court litigation by specifying instances where discretionary denial could not be issued. With the withdrawal of the memorandum, individual PTAB panels will regain flexibility in weighing discretionary denials. While the long-term effect of that increased flexibility is not yet known, the immediate effect is likely to be a shift towards the discretionary analysis applied by PTAB panels before the issuance of the memorandum.

...

Read More

IP Newsflash

March 3, 2025

A District of Delaware judge recently granted a defendant’s motion to include a patent prosecution bar in its proposed protective order after determining that litigation counsel’s ability to practice before the Patent Office—without ever having represented the plaintiffs at the Patent Office in the past—weighed heavily in favor of the bar.

...

Read More

IP Newsflash

February 12, 2025

The Federal Circuit recently reversed a district court decision that found a patent that did not describe after-arising technology failed to satisfy the written description requirement. In so doing, the Federal Circuit explained that written description and enablement are evaluated based on the subject matter that is claimed, not the products that practice those claims. As a result, the patentee was not required to describe unclaimed, later-discovered features of the accused products despite the broad language in the claims that undisputedly covered the products.

...

Read More

IP Newsflash

January 24, 2025

The District of Delaware recently rejected a patentee’s argument that non-production of an opinion letter from counsel, combined with knowledge of the patent, warranted a finding that defendant induced infringement.

...

Read More

IP Newsflash

January 17, 2025

The District of Delaware recently denied a motion to dismiss a patent infringement complaint involving gene editing technology that sought relief under the Safe Harbor Provision of the Hatch-Waxman Act. Specifically, the court found the patentee’s complaint sufficiently alleged at least some uses of the claimed technology that, when taken as true, were not solely uses of a “patented invention” that were “reasonably related” to an FDA submission.

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.